Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Early Phase Hub consists of a team of trial administrators dedicated to facilitating the opening and ongoing regulatory conduct of trials being run through the Early Phase Clinical Trials Unit, Late phase Oncology Team and Late Phase Haematology Team.

The trial administrators are responsible for all non-clinical regulatory aspects of the trials, throughout their lifetime.  All Oxford site set up activities are coordinated via the hub as a single point of contact.  The hub approaches and engages all the necessary support departments (pharmacy, radiology, path labs etc) required by the protocol and liaises with R&D for confirmation of capability and capacity and arrange the site initiation visit.  We endeavour to achieve site initiation 60 days from acceptance into our pipeline and receipt of a full regulatory document set.